Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring ...

Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss of 15 cents. The Zacks Consensus Estimate is pegged at a loss per share of ...

Nevro (NVRO) came out with a quarterly loss ... A quarter ago, it was expected that this maker of an electrical implant that treats leg and back pain would post a loss of $0.82 per share when ...

Total U.S. permanent implant procedures declined 7% year over year, while U.S. trial procedures decreased 14.2% year over year. During the fourth quarter of 2024, Nevro made significant ...

The Redwood City, California-based company said it had a loss of $1.41 per share. Losses, adjusted for one-time gains and costs, came to 64 cents per share. The results surpassed Wall Street ...

(AP) — Nevro Corp. (NVRO) on Tuesday reported a loss ... Advertisement Article continues below this ad The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 ...

(AP) — Nevro Corp. (NVRO) on Tuesday reported a loss ... The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also beat Street ...

March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering ... minimized bone removal and increased fusion potential compared to a posterolateral ...